Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. LXRX has several positive signals and is within a rising trend, so we believe it will perform strongly in the next couple of days or weeks. We therefore hold a positive evaluation of this stock. Our analysis conclusion for this stock is a Strong Buy candidate.
LXRX stock price ended at $0.7455 on Wednesday, after rising3.47%
The Lexicon Pharmaceuticals Inc stock price increased by 3.47% on the last trading day (18 Jun 2025), rising from 0.71 to 0.7455. Throughout the last trading session, the stock experienced a fluctuation of 9.45% , ranging from a day low of $0.703 to a day high of 0.7694. The price has declined in 5 of the last 10 days, resulting in a total change of 12.77% during this period. On the last day, trading volume decrease by -1.03M shares, with the rising prices. This could serve as an early warning, indicating that risk may slightly increase in the coming days. In total, 3.61M shares were traded, amounting to approximately 2.68M.
LXRX Technical Signals
LXRX(Lexicon Pharmaceuticals Inc Corp) has 3 buy signals and 1 sell signal now. The current trend is uptrend starting from 2025-06-02. The total price change during this trend is +19.93%. Recently, the price has increased but the volume has decreased, indicating a potential warning signal. The average turnover of LXRX over the last 5 trading days is 2.42M. Overall, the technical indicator signals lean more toward a Bullish outlook in the mid-term.
LXRX Moving Average Analysis
Lexicon Pharmaceuticals Inc's overall moving average trend leans more bullish as of Friday, June 20, 2025, with 1 negative signals and 3 positive signal. In the mid-term, the SMA_20 being above the SMA_60 signals a strong bullish trend. There will be some resistance from the lines at $0.8127274, and $0.87358. A break-up above any of these levels will issue buy signals. There will be some support from the lines at $0.6158326000000001, and $0.55498. A break-down below any of these levels will issue sell signals.
LXRX Short Selling Analysis
The short sale ratio of Lexicon Pharmaceuticals Inc(LXRX) as of 17 Jun 2025 is 35.69%, dropping from last trading day. With decreasing price from 0.67 to 0.72. The short sell activity indicate that short sellers may be experiencing short cover.
Technical Signal
Technical Signals Summary
Sell
1
Buy
3
Moving Average
Swing
Positive
Stock Price Above SMA_5
Short Term
Positive
SMA_5 Above SMA_20
Mid Term
Positive
SMA_20 Above SMA_60
Long Term
Negative
SMA_60 Below SMA_200
Short Selling
Close Price
Short Sale Ratio
Short Sale Volume
3 Bullish Signals
3 Bullish Signals
When Value satisfies Signal, Indicator signals Bullish
Indicators
Signal
Value
Meaning
Awesome Oscillator (5, 34)
AO_5_34 > 0
0.0351
Bullish
Momentum (10 days)
MOM_10 > 0
0.0844
Bullish
Moving Average Convergence Divergence (12, 26, 9)
MACD_12_26_9 > 0
0.0248
Bullish
1 Bearish Signals
1 Bearish Signals
When Value satisfies Signal, Indicator signals Bearish
Indicators
Signal
Value
Meaning
Commodity Channel Index (20 days, 0.015 constant)
CCI_20_0.015 > 100
107.095
Bearish
LXRX Price Prediction & Forecast by Similar Chart Analysis
Based on historical patterns and backtesting of stocks with similar movements to Lexicon Pharmaceuticals Inc(LXRX), our algorithm predicts LXRX's 1-month price at $0.64, with an -4.3%downwardshift. Using a similarity score up to 94.49%and other factors, This forecast updates weekly, adjusting for significant deviations.
Similar Chart
The price prediction chart for Lexicon Pharmaceuticals Inc (LXRX.O) stock, as of Sunday, June 15, 2025 , forecasts a -4.3% change over the next month, based on its high correlation with NOG.N stock patterns. The similarity between their price movements over the analyzed periods is 94.49%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
LXRX
No Data
NOG
Down: -4.3%Similarity: 94.49%
Name
Similarity
Up/Down
NOG.N
94.49%
-4.30%
PLUG.O
93.95%
+66.42%
PFX.O
93.16%
+4.17%
HDB.N
92.29%
+16.05%
CCI.N
92.23%
-4.19%
EQT.N
92.11%
+11.06%
CNNE.N
92.04%
+15.47%
ZD.O
91.91%
+8.85%
RACE.N
91.91%
+14.34%
HCI.N
91.83%
-12.36%
LXRX Seasonality Analysis
Based on LXRX's historical stock price data across all years, the probability of a positive return in June is81.82%, suggesting it maybe an ideal month to invest in LXRX. In contrast,Juneoffers the highest probability of positive returns at81.82%, making it a potentially strong month for investment.
However, this is only a prediction based on one method, and a comprehensive assessment of the stock's future trend should consider additional factors. Our final stock price commentary incorporates three main evaluation dimensions: technical signals, Moving Average trends, and similar chart pattern matching, with the first two dimensions carrying the primary weight to ensure a more robust and accurate forecast.
Monthly Seasonality
The radar chart shows that buying Lexicon Pharmaceuticals Inc (LXRX.O) stock in June has the highest probability of a positive return (81.82%), while August has the lowest probability (30.00%).
Performance Seasonality
The chart shows Lexicon Pharmaceuticals Inc. (LXRX)'s annual stock price return for the past three years, helping you analyze price trends and identify recurring trends on an annual basis.
People Also Watch
FAQ
Should I buy Lexicon Pharmaceuticals Inc (LXRX.O) stock?
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. LXRX has several positive signals and is within a rising trend, so we believe it will perform strongly in the next couple of days or weeks. We therefore hold a positive evaluation of this stock. Our analysis conclusion for this stock is a Strong Buy candidate.
Which months have the highest win rate for buying Lexicon Pharmaceuticals Inc (LXRX.O) stock in a year?
The radar chart shows that buying Lexicon Pharmaceuticals Inc (LXRX.O) stock in June has the highest probability of a positive return (81.82%), while August has the lowest probability (30.00%).
How has Lexicon Pharmaceuticals Inc. (LXRX)'s stock price performed over the past three years?
LXRX's stock price fell by -23.12% in 2023,decreased by -53.55% in 2024, and went down by 4.07% in 2025.
Bearish technical signals of LXRX include: CCI_20_0.015 > 100.
Is LXRX a buy based on overall technical signals summary?
LXRX has 3 buy signals and 1 sell signals now. Overall the technical rating for LXRX is Buy . Note that market conditions change all the time. In addition to technical ratings, keep an eye on the Valuation Level of LXRX.
What is the trend of Lexicon Pharmaceuticals Inc (LXRX)'s moving average?
Lexicon Pharmaceuticals Inc's overall moving average trend leans more bullish as of June 20 2025, with 1 negative signals and 3 positive signal.
What is price prediction for LXRX stock next month?
The price prediction chart for Lexicon Pharmaceuticals Inc (LXRX.O) stock, as of June 15 2025, forecasts a -4.3% change over the next month, based on its high correlation with NOG stock patterns. The similarity between their price movements over the analyzed periods is 94.49%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
What is price prediction 2025 for LXRX Stock?
### **Price Prediction for LXRX Stock in 2025**
Based on the analysis of Lexicon Pharmaceuticals' (LXRX) current performance, technical indicators, and recent news, here is a concise price prediction:
1. **Current Price and Technical Outlook**:
LXRX is currently trading at **$0.73** as of June 10, 2025. The stock shows a bullish trend with improving technical indicators, including a rising RSI (63.57) and Stochastic Oscillator (%K at 83.67).
2. **Fundamental Drivers**:
- Lexicon recently secured a significant partnership with Novo Nordisk for LX9851, receiving $45 million upfront and potential payments exceeding $1 billion.
- The company is advancing pilavapadin into Phase 3 trials for diabetic peripheral neuropathic pain, with a clear path forward.
3. **Price Prediction**:
- **Target Price**: $1.20 by the end of 2025.
- **Reason**: The stock is undervalued given its pipeline progress and partnerships, with analysts maintaining a buy rating and a consensus target of $3.83.
What is price prediction 2030 for LXRX Stock?
### **Price Prediction for LXRX Stock by 2030**
Based on current trends and partnerships, LXRX is predicted to reach **$2.50 to $4.00 by 2030**, driven by its Novo Nordisk partnership and advancing drug pipeline.
The stock is currently undervalued with strong fundamentals, including a $1 billion potential deal with Novo Nordisk and a solid cash position of $194.8 million.